Related Experiment Videos

Continuous arteriovenous hemofiltration attenuates polymorphonuclear leukocyte phagocytosis in porcine

A W DiScipio1, K W Burchard

  • 1Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756-0001, USA.

Abstract

Insights

Continuous arteriovenous hemofiltration (CAVH) reduces polymorphonuclear leukocyte (PMN) phagocytosis during sepsis. This effect is temporary, highlighting a potential link between CAVH and immune cell function in systemic inflammation.

Area of Science:

  • Critical care medicine
  • Immunology
  • Nephrology

Background:

  • Systemic inflammation involves polymorphonuclear leukocyte (PMN) activation, potentially causing organ dysfunction.
  • Continuous arteriovenous hemofiltration (CAVH) may improve organ function in severe inflammation.
  • This study investigates if CAVH impacts PMN activation.

Purpose of the Study:

  • To determine the effect of CAVH on PMN activation during sepsis.
  • To explore the relationship between CAVH, PMN phagocytosis, and sepsis manifestations.

Main Methods:

  • A sepsis model was induced in 16 pigs via cecal ligation and rupture.
  • Animals were randomized to receive either CAVH or no CAVH for 24 hours.
  • Polymorphonuclear leukocyte (PMN) phagocytosis of Candida was measured, along with other physiological parameters.

Main Results:

  • CAVH attenuated the upregulation of PMN phagocytosis of Candida observed in the control group.
  • Phagocytic capacity returned to control levels after CAVH discontinuation.
  • No significant differences were found in hemodynamic, pulmonary, or ionized calcium levels between groups.

Conclusions:

  • Continuous arteriovenous hemofiltration (CAVH) temporarily reduces PMN phagocytosis capacity during sepsis.
  • The observed effect on PMN phagocytosis is reversible upon cessation of CAVH.
  • Certain sepsis manifestations may not be directly linked to PMN phagocytosis capacity.

Related Concept Videos